Institutional Venture Management XV’s Hims & Hers Health HIMS Stock Holding History

Institutional Venture Management XV’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,597,558	Closed	-$47.8M	–	5
2024 Q3	$47.8M	Hold	2,597,558	–	–	26.51%	2
2024 Q2	$52.4M	Sell	2,597,558 -2,625,000	-50%	-$43.7M	35.85%	2
2024 Q1	$80.8M	Sell	5,222,558 -2,500,000	-32%	-$28.2M	41.61%	2
2023 Q4	$68.7M	Hold	7,722,558	–	–	33.4%	2
2023 Q3	$48.6M	Buy	7,722,558 +12,829	+0.2%	+$95.4K	28.58%	2
2023 Q2	$72.5M	Buy	7,709,729 +1,225	+0%	+$12.1K	28.51%	2
2023 Q1	$76.5M	Sell	7,708,504 -2,500,574	-24%	-$21.9M	22.38%	2
2022 Q4	$65.4M	Buy	10,209,078 +7,346	+0.1%	+$41.8K	21.19%	3
2022 Q3	$56.9M	Hold	10,201,732	–	–	16.51%	3
2022 Q2	$46.2M	Hold	10,201,732	–	–	13.21%	3
2022 Q1	$54.4M	Hold	10,201,732	–	–	9.98%	5
2021 Q4	$66.8M	Hold	10,201,732	–	–	8.11%	5
2021 Q3	$76.9M	Buy	10,201,732 +15,206	+0.1%	+$129K	7.18%	5
2021 Q2	$111M	Buy	10,186,526 +907,657	+10%	+$10.8M	15.54%	4
2021 Q1	$123M	Buy	+9,278,869	New	+$156M	61.54%	1

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Institutional Venture Management XV's HIMS Position: Q4 2024 in Review

Institutional Venture Management XV sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 2,597,558 shares — an estimated $47.8M sold.

Institutional Venture Management XV first reported a position in HIMS in Q1 2021 and held it in 15 quarters. The position peaked at $123M in Q1 2021. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

Institutional Venture Management XV reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
Institutional Venture Management XV sold 2,597,558 Hims & Hers Health shares in Q4 2024, an estimated $47.8M.
Institutional Venture Management XV first reported a position in Hims & Hers Health in Q1 2021 and held it in 15 quarters.
Institutional Venture Management XV's Hims & Hers Health position peaked at $123M in Q1 2021.
394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Institutional Venture Management XV's 13F filing for Q4 2024, filed 14 Feb 2025.